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Persistent reovirus infections of murine L929 cells select cellular mutations that inhibit viral disassembly
within the endocytic pathway. Mutant cells support reovirus growth when infection is initiated with infectious
subvirion particles (ISVPs), which are intermediates in reovirus disassembly formed following proteolysis of
viral outer-capsid proteins. However, mutant cells do not support growth of virions, indicating that these cells
have a defect in virion-to-ISVP processing. To better understand mechanisms by which viruses use the
endocytic pathway to enter cells, we defined steps in reovirus replication blocked in mutant cells selected
during persistent infection. Subcellular localization of reovirus after adsorption to parental and mutant cells
was assessed using confocal microscopy and virions conjugated to a fluorescent probe. Parental and mutant
cells did not differ in the capacity to internalize virions or distribute them to perinuclear compartments. Using
pH-sensitive probes, the intravesicular pH was determined and found to be equivalent in parental and mutant
cells. In both cell types, virions localized to acidified intracellular organelles. The capacity of parental and
mutant cells to support proteolysis of reovirus virions was assessed by monitoring the appearance of disas-
sembly intermediates following adsorption of radiolabeled viral particles. Within 2 h after adsorption to
parental cells, proteolysis of viral outer-capsid proteins was observed, consistent with formation of ISVPs.
However, in mutant cells, no proteolysis of viral proteins was detected up to 8 h postadsorption. Since
treatment of cells with E64, an inhibitor of cysteine-containing proteases, blocks reovirus disassembly, we used
immunoblot analysis to assess the expression of cathepsin L, a lysosomal cysteine protease. In contrast to
parental cells, mutant cells did not express the mature, proteolytically active form of the enzyme. The defect
in cathepsin L maturation was not associated with mutations in procathepsin L mRNA, was not complemented
by procathepsin L overexpression, and did not affect the maturation of cathepsin B, another lysosomal cysteine
protease. These findings indicate that persistent reovirus infections select cellular mutations that affect the
maturation of cathepsin L and suggest that alterations in the expression of lysosomal proteases can modulate
viral cytopathicity.
Mammalian reoviruses are nonenveloped, icosahedral vi-
ruses that contain a genome of 10 double-stranded RNA gene
segments. Many viruses, including reovirus, require endocytic
uptake and exposure to acidic pH or acid-dependent proteases
to productively infect host cells. Following reovirus attachment
to cells, virions are observed by electron microscopy in clath-
rin-coated pits, which suggests that viral entry occurs by recep-
tor-mediated endocytosis (12, 13, 47, 55). Within late endo-
somes or lysosomes, viral outer-capsid proteins s3 and m1 are
subject to proteolysis by vacuolar proteases, yielding infectious
subvirion particles (ISVPs) (13, 17, 52, 55). ISVPs generated in
the endocytic compartment are indistinguishable from those
generated either in the intestinal lumen of perorally infected
mice (9, 10, 19) or in vitro by treatment of virions with chy-
motrypsin or trypsin (13, 17, 44, 52, 55). ISVPs are obligate
intermediates in reovirus disassembly that mediate penetration
of the virus into the cytoplasm (12, 30, 31, 36, 58).
Treatment of cells with ammonium chloride (10, 22, 55) or
inhibitors of the vacuolar proton ATPase, such as bafilomycin
or concanamycin A (38), blocks infection by virions but not by
ISVPs, which indicates that intracellular proteolysis of the s3
and m1 proteins is acid dependent. The vacuolar proteases that
mediate cleavage of reovirus outer-capsid proteins have not
been identified. However, treatment of cells with E64, a spe-
cific inhibitor of proteases containing active-site cysteine resi-
dues (7), blocks proteolysis of s3 and m1 during viral entry (6,
16). In contrast, pepstatin, a specific inhibitor of aspartyl pro-
teases (20), does not inhibit proteolysis of s3 and m1 and does
not inhibit reovirus growth (35). These findings indicate that a
cysteine protease is required for endocytic proteolysis of the
reovirus outer capsid.
Studies of persistent reovirus infections of murine L929 (L)
cells have contributed significantly to an understanding of re-
ovirus entry and disassembly (reviewed in reference 21). In
contrast to wild-type (wt) viruses, viruses isolated from persis-
tently infected cultures can grow in cells treated with ammo-
nium chloride (22, 62) and E64 (6). These findings suggest that
mutant viruses have altered requirements for decreased pH
and proteolysis to complete the steps in entry required for
generation of ISVPs. When persistently infected cultures of L
cells are cured of reovirus infection by treatment with an an-
tireovirus antiserum, the resulting cells do not fully support
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growth of wt viruses (22). However, when virions of wt viruses
are first converted to ISVPs by protease treatment in vitro,
they grow efficiently in cured cells (22, 61). These findings
indicate that cellular mutations selected during persistent re-
ovirus infection affect steps in reovirus replication required for
formation of ISVPs. The nature of the cellular mutation that
leads to a block in virion-to-ISVP conversion is not known.
In this study, we used reovirus virions and ISVPs as probes
to define steps in reovirus replication blocked in mutant cells
selected during persistent reovirus infection. We compared the
ability of parental and mutant cells to support each step in the
reovirus entry pathway and found that mutant cells are defec-
tive in maturation of the lysosomal cysteine-containing pro-
tease cathepsin L. These findings indicate that persistent reo-
virus infection selects a novel class of mutant cells defective in
cathepsin L processing or transport and suggest that cathepsin
L is required for disassembly of reovirus virions.
MATERIALS AND METHODS
Cells and viruses. Murine L cells were grown in either suspension or mono-
layer cultures in Joklik’s modified Eagle’s minimal essential medium (Irvine
Scientific, Santa Ana, Calif.) supplemented to contain 5% fetal bovine serum
(Intergen, Purchase, N.Y.), 2 mM L-glutamine, 100 U of penicillin per ml, 100 mg
of streptomycin per ml, and 0.25 mg of amphotericin (Irvine Scientific) per ml.
Mutant LX cells were grown in monolayer cultures in Joklik’s modified Eagle’s
minimal essential medium supplemented to contain 10% fetal bovine serum, 2
mM L-glutamine, 100 U of penicillin per ml, 100 mg of streptomycin per ml, and
0.25 mg of amphotericin per ml. Reovirus strains type 1 Lang (T1L) and type 3
Dearing (T3D) are laboratory stocks. Purified virion preparations were made
with second-passage L-cell lysate stocks of twice-plaque-purified reovirus, as
previously described (23). Purified virions containing 35S-labeled proteins were
obtained by adding Easy Tag Express-[35S] protein labeling mix (NEN, Boston,
Mass.) to cell suspensions (;12.5 mCi per ml) at the initiation of infection. ISVPs
were prepared by treating purified reovirus virions with Na-p-tosyl-L-lysine chlo-
romethyl ketone-treated bovine a-chymotrypsin (Sigma Chemical Co., St. Louis,
Mo.) as previously described (6). T1L was used in experiments represented by
Fig. 1, 3, 5, 6, and 10 since the ratio of particles to PFU is the same for virions
and ISVPs of this strain (44). Particle-to-PFU ratios of the T1L virion and ISVP
preparations used in this study were 100 to 1.
Establishment of persistent reovirus infections. Monolayer cultures of L cells
(5 3 106 cells) were infected with second-passage L-cell lysate stocks of twice-
plaque-purified reovirus T3D at a multiplicity of infection (MOI) of 0.1 PFU per
cell. The cultures were either passaged when confluent or supplemented with
fresh medium every 4th day if the cell density was not sufficient to permit
passage. Cell culture lysates were collected at each passage by two cycles of
freezing and thawing (270 and 37°C). Viral titer in cell culture lysates was
determined by plaque assay with L-cell monolayers (60).
Isolation of cells cured of persistent reovirus infection. Persistently infected
L-cell cultures were rendered virus free by maintenance in medium supple-
mented to contain 1% rabbit antireovirus antiserum (61) for 30 days. Cells cured
of persistent reovirus infection were termed LX cells. Cured-cell clones were
obtained by two cycles of limiting dilution into 96-well plates (Costar, Cam-
bridge, Mass.). Individual wells were inspected visually, and only those contain-
ing a single colony were used. Cell clones presumed to be virus free were assessed
by plaque assay of cell culture supernatants, infectious center assay, and immu-
nocytochemical staining with rabbit antireovirus antiserum.
Growth of reovirus in parental L cells and mutant LX cells. Monolayers of L
cells and LX cells (5 3 105 cells) in 24-well plates (Costar) were infected with
reovirus strains at an MOI of 2 PFU per cell. After 1 h of adsorption at 4°C, the
inoculum was removed, cells were washed twice with phosphate-buffered saline
(PBS), and 0.5 ml of fresh medium was added. After incubation at 37°C for 24 h,
cells were frozen and thawed twice and viral titers in cell lysates were determined
by plaque assay with L-cell monolayers (60). Independent experiments were
performed with single wells of cells, which were titrated in duplicate.
Electron microscopy. Cells were centrifuged to form a pellet (1,000 3 g, 10
min) and suspended in phosphate-buffered 2% glutaraldehyde. After primary
fixation, cells were again centrifuged (1,000 3 g, 10 min), resuspended in 1%
osmium tetroxide, dehydrated in increasing percentages of ethanol (50 to 100%)
and propylene oxide, and then embedded in an epoxy resin. Ultrathin sections
were prepared with an Ultratome III ultramicrotome (LKB, Piscataway, N.J.)
and stained with lead citrate and uranyl acetate. Sections were examined with a
Philips 300 electron microscope (Philips, Mahwah, N.J.).
Conjugation of reovirus virions to fluorescent dyes. Purified reovirus virions of
strain T1L (5 3 1013 particles per ml) were dialyzed at 4°C against 100 mM
sodium bicarbonate-buffered 0.8% saline (pH 8.5 for 2 h followed by pH 9.3 for
2 h). Cy3 or Cy5 monofunctional reactive dye (Amersham, Arlington Heights,
Ill.) was added to viral suspensions and incubated at 25°C for 45 min. Conjugated
virus was dialyzed at 4°C for 16 h against PBS to remove free dye. Conjugation
of reovirus virions with fluorescent dyes results in labeling of viral outer-capsid
proteins s1, s3, m1, and l2 and a fivefold decrease in viral infectivity.
Confocal microscopy of reovirus uptake and trafficking. L cells and LX cells
(105) were grown on 12-mm glass coverslips (Fisher Scientific, Pittsburgh, Pa.) or
in glass-bottomed MatTek dishes (MatTek Corp., Ashland, Mass.) for 2 days.
Monolayers of cells at approximately 70% confluence were incubated at 4°C for
20 min prior to adsorption with fluorescent conjugated reovirus virions at an
MOI of 10,000 particles per cell, the minimum number of reovirus particles
sufficient to detect a signal. After adsorption at 4°C for 45 min, cells were
incubated at 37°C for various intervals, washed three times with PBS, and fixed
for 5 min in a 1:1 mixture of methanol and acetone. Cells were washed three
times in PBS and mounted on glass slides with Aqua-Poly/Mount (Polysciences,
Inc., Warrington, Pa.). Cells were examined with a Zeiss confocal fluorescence
microscope (Carl Zeiss, New York, N.Y.).
Determination of intravesicular pH. L cells and LX cells (105) were grown in
MatTek dishes for 2 days. Cells were incubated with 0.1% (wt/vol) double-
labeled fluorescein-tetramethylrhodamine dextran (Molecular Probes, Eugene,
Oreg.), which contains pH-dependent (fluorescein) and pH-independent (tetra-
methylrhodamine) dyes, at 37°C for 16 h. To generate a standard curve corre-
lating the fluorescein-to-tetramethylrhodamine (F/TMR) fluorescence ratio with
pH, cells were fixed in 1:1 methanol and acetone and permeabilized in PBS with
1% Triton X-100. Cells were equilibrated for 1 h in buffers of various pHs—0.1
M sodium acetate (pH 4.0 and 5.0), 0.1 M sodium phosphate (pH 6.0 and 7.0),
and 0.1 M Tris (pH 8.0)—and then cells were examined by confocal fluorescence
microscopy. Fluorescence intensities for fluorescein and tetramethylrhodamine
were determined for identical groups of 15 to 20 cells at each pH standard by
using NIH Image software. A standard curve was generated by correlating the
F/TMR fluorescence ratio with pH. To determine the intravesicular pH of
parental L cells and mutant LX cells, cells were incubated with the double-
labeled dextran at 37°C for 16 h, washed in Dulbecco’s modified Eagle’s medium
(Gibco BRL, Grand Island, N.Y.), and examined with a confocal fluorescence
microscope. Fluorescence intensities for fluorescein and tetramethylrhodamine
were determined for identical groups of cells by using NIH Image. The intrave-
sicular pH of parental L cells and mutant LX cells was determined by calculating
the mean F/TMR fluorescence ratio for each cell type and extrapolating from the
standard curve.
LysoSensor Green staining of cells. L cells and LX cells (105) were grown in
MatTek dishes for 2 days. Cells were washed once with PBS, and 2 ml of fresh
Dulbecco’s modified Eagle’s medium without phenol red (Gibco BRL) was
added. Cells were incubated at 37°C for 1 h, and the medium was removed and
replaced with 0.5 ml of medium containing 3 mM LysoSensor Green DND-189
probe (Molecular Probes). Cells were incubated with probe for 1.5 h, washed two
times with fresh medium without probe, and examined by confocal fluorescence
microscopy.
Assessment of intracellular proteolysis of reovirus virions. L cells and LX cells
(107) in 75-cm2 flasks (Costar) were adsorbed with purified, 35S-labeled reovirus
virions at 10,000 particles per cell. After incubation at 4°C for 1 h, the inoculum
was removed, cells were washed twice with PBS, and 10 ml of fresh medium was
added. After incubation at 37°C for various intervals, cells were harvested,
resuspended in 0.5 ml of lysis buffer (150 mM NaCl, 10 mM Tris [pH 7.4], 0.5%
Nonidet P-40 [NP-40], 1 mM EDTA, 1 mM benzamidine, 100 mM leupeptin, and
2.5 mM phenylmethylsulfonyl fluoride), and placed on ice for 30 min. After the
addition of 4.5 ml of homogenization buffer (250 mM NaCl, 10 mM Tris [pH 7.4],
0.067% 2-mercaptoethanol), samples were sonicated for 1 min, 2.5 ml of freon
(EM Science, Gibbstown, N.J.) was added, and samples were again sonicated for
1 min. Samples were centrifuged at 9,700 3 g for 10 min, and viral particles in the
aqueous fraction were pelleted by centrifugation at 210,000 3 g for 1 h.
Virus particles were solubilized by incubation in sample buffer (125 mM Tris,
2% 2-mercaptoethanol, 1% sodium dodecyl sulfate [SDS], 0.01% bromphenol
blue) at 100°C for 5 min. Samples were loaded into wells of 10% polyacrylamide
gels and electrophoresed at 200 V of constant voltage for 1 h. Following elec-
trophoresis, gels were fixed, dried onto filter paper (Bio-Rad Laboratories,
Richmond, Calif.) under vacuum, and exposed to BioMax-MR film (Eastman
Kodak Co., Rochester, N.Y.).
Immunoblot analysis for cathepsin L and cathepsin B. L cells and LX cells
(107) in 75-cm2 flasks were pretreated overnight with 0 or 200 mM E64 (Sigma).
Following 6 h of incubation in 3 ml of serum-free medium supplemented to
contain 0 or 200 mM E64, culture supernatants were removed and cells were
harvested in 5 ml of PBS. Cells were pelleted and washed in PBS, followed by
incubation in RIPA buffer (1% NP-40, 0.5% deoxycholate, 0.1% SDS) with 2.5
mM phenylmethylsulfonyl fluoride, 1 mM EDTA, and protease inhibitor cocktail
(Boehringer Mannheim, Indianapolis, Ind.) at 4°C for 5 min. Samples were
vortexed vigorously for 10 s, and membranes and nuclei were pelleted by cen-
trifugation at 13,000 3 g. Supernatants were assayed for protein content by using
the Bio-Rad DC protein assay and diluted in immunoblot-polyacrylamide gel
electrophoresis (PAGE) sample buffer (3.3% SDS, 80 mM Tris [pH 7], 20%
sucrose, 0.008% bromphenol blue, 17 mM EDTA, 17 mM dithiothreitol [DTT])
(18). Secreted proteins in culture supernatants were precipitated with 20% tri-
chloroacetic acid containing salmon sperm DNA (25 mg per ml), centrifuged at
12,000 3 g for 10 min, and resuspended in immunoblot-PAGE sample buffer.
Protein samples, normalized for either protein content (cellular proteins) or
VOL. 73, 1999 REOVIRUS SELECTS MUTANT CELLS DEFECTIVE IN CATHEPSIN L 9533
cell number (secreted proteins), were loaded into lanes of 12% polyacrylamide
gels and electrophoresed at 200 V of constant voltage for 50 min. Following
equilibration of the gel in transfer buffer (25 mM Tris, 192 mM glycine, 20%
methanol) for 20 min, proteins were transferred to nitrocellulose membranes
either overnight at 30 V or for 1 h at 100 V. After removal from the transfer
apparatus, membranes were air dried for 5 min and treated for 1 h with agitation
in Tris-buffered saline (TBS) (50 mM Tris [pH 7.5], 150 mM NaCl) containing
0.05% Tween 20 and 5% low-fat dry milk. Membranes were incubated at 37°C
for 2 h with agitation in antiserum against murine cathepsin L (45) or human
cathepsin B (Athens Research and Technology, Athens, Ga.) diluted 1:15,000
(anti-cathepsin L) or 1:2,000 (anti-cathepsin B) in TBS plus Tween 20 and milk.
After three washes in TBS plus Tween 20, membranes were incubated at 25°C for
1 h with agitation in horseradish peroxidase-conjugated goat anti-rabbit second-
ary antibody (Amersham) diluted 1:2,500 in TBS plus Tween 20 and milk.
Membranes were washed three times in TBS plus Tween 20, incubated with
Enhanced chemiluminescent reagent (Amersham) for 1 min, and exposed to
Biomax-MR film.
Cloning and sequencing of procathepsin L-encoding cDNA. Cellular mRNA
was purified from cell lysates with oligo(dT) magnetic beads (Dynal, Oslo, Nor-
way). Oligodeoxynucleotide primers 59-AGACTTCTTGTGCGCACGTA and
59-CGACACACACACTGAGCTAA, which correspond to the 59 and 39 non-
translated regions of the procathepsin L cDNA, were used to generate PCR
products from isolated mRNA. Purified mRNA was melted in 90% dimethyl
sulfoxide at 95°C for 5 min. Ice-cold primers were annealed to the melted
template, and cDNA was generated with avian myeloblastosis virus reverse
transcriptase (RT) (Boehringer Mannheim). PCR was performed with Taq poly-
merase (Perkin-Elmer, Branchburg, N.J.) for 39 cycles with a program of tem-
plate denaturation at 95°C for 2 min, primer annealing at 55°C for 2 min, and
polynucleotide synthesis at 72°C for 5 min. PCR was completed by a synthesis
step at 72°C for 1 h. Resultant cDNAs were cloned into the pCRII vector
(Invitrogen, San Diego, Calif.). Unambiguous sequences of 1,354 nucleotides of
the procathepsin L cDNA, including the entire open reading frame of the
preprocathepsin L protein, were determined by dideoxy chain termination with
T7 DNA polymerase (United States Biochemical, Cleveland, Ohio). Two cDNA
clones generated from independent RT-PCRs were used as template in these
experiments.
Transfection of cells with a procathepsin L-encoding cDNA. A cDNA encod-
ing murine procathepsin L was cloned into eukaryotic expression vector pSG5
(Stratagene, La Jolla, Calif.) and introduced into L cells and LX cells in 85-mm
plates (Costar) by using LipofectAMINE (Life Technologies, Inc., Rockville,
Md.) according to previously described techniques (18). After incubation at 37°C
for 48 h, the medium was replaced with serum-free medium supplemented with
insulin, ferritin, and sodium selenite. After an additional 24 h of incubation, cell
lysates and culture supernatants were prepared and immunoblot analysis was
performed with cathepsin L-specific antiserum (45) as described.
Treatment of reovirus virions with cathepsin L. Purified virions of reovirus
strain T1L at a concentration of 3 3 1012 particles per ml in virion storage buffer
(100 mM NaCl, 15 mM MgCl2, 50 mM sodium acetate) adjusted to pH 5.0 were
treated with 150 mg of purified recombinant human cathepsin L (15) per ml in
the presence of 5 mM DTT at 37°C for various intervals. Cathepsin L treatment
was stopped by adding 500 mM E64 to the treatment mixtures and freezing at
220°C. Aliquots of the treatment mixtures were mixed 5:1 with 63 sample buffer
(350 mM Tris [pH 6.8], 9.3% DTT, 10% SDS, 0.012% bromphenol blue) and
incubated at 100°C for 5 min. Samples were loaded into wells of 10% polyacryl-
amide gels and electrophoresed at 200 V of constant voltage for 1 h. Gels were
stained with Coomassie blue R-250 (Sigma) and dried between cellophane.
Aliquots of the treatment mixtures also were used to inoculate L cells and LX
cells at an MOI of 2 PFU per cell. After incubation at 37°C for 24 h, cells were
frozen and thawed twice and viral titers in cell lysates were determined by plaque
assay with L-cell monolayers (60).
Nucleotide sequence accession numbers. The procathepsin L-encoding cDNA
sequences determined in this study have been deposited in GenBank and as-
signed accession no. AF121837 (L cells), AF121838 (LXA1 cells), and AF121839
(LXB2 cells).
RESULTS
Establishment of L-cell cultures persistently infected with
reovirus. Persistently infected cultures of L cells have been
established previously with virus stocks passaged serially at
high MOI (3, 4, 14, 22). Such stocks contain a variety of viral
mutants (2, 5), and these mutants are postulated to facilitate
establishment of persistent infection (14). To determine
whether persistent infection also can be established with reo-
virus stocks passaged at low MOI, and to select cells containing
blocks to reovirus infection, murine L cells were infected with
independent, second-passage L-cell lysate stocks of reovirus
strain T3D at an MOI of 0.1 PFU per cell. Two independent,
persistently infected cultures, termed LDG and LDV, were
established. Following approximately 4 days in culture, both
cell lines underwent an intense period of crisis in which most of
the cells in the cultures were lysed. Over the next 2 to 3 weeks,
small colonies of cells became apparent and these colonies
eventually reached sufficient density to permit passage. The
LDG and LDV cultures were maintained for approximately 1
year and produced titers of infectious virus of between 106 and
108 PFU per ml throughout their maintenance period (data
not shown). These observations confirm that L-cell cultures
persistently infected with reovirus produce high titers of infec-
tious virus for prolonged periods (1, 4, 22) and demonstrate
that wt reovirus can initiate a persistent infection when cul-
tures are inoculated at low MOI.
Growth of reovirus virions and ISVPs in parental L cells
and mutant LX cells cured of persistent infection. To isolate
virus-free mutant cells for studies of reovirus entry, a neutral-
izing antireovirus antiserum (61) was added to the medium of
subcultures of both the LDG and LDV cell lines at 230 days of
culture maintenance. Antiserum treatment was continued for a
30-day period, during which time the viral titer decreased to
undetectable levels (,10 PFU per ml of culture supernatant)
for each culture. Following antiserum treatment of LDG and
LDV, the resulting cultures, termed LXDG and LXDV, re-
spectively, were passaged in medium without antiserum. The
cured cell lines were confirmed to be virus free by the absence
of virus in culture lysates, negative infectious center assays, and
absence of detectable viral antigen by immunocytochemistry
(data not shown).
To obtain a homogeneous population of cells for character-
ization of blocks to reovirus entry, cells were cloned from the
cured LXDG culture by two cycles of limiting dilution. Eight
LXDG subclones were established, and these subclones were
tested for the capacity to support reovirus entry. Parental L
cells and the eight LXDG subclones were infected with either
virions or ISVPs of reovirus strain T1L at an MOI of 2 PFU
per cell, and viral titers in cell lysates were determined after
24 h of viral growth (Fig. 1). Viral titers after infection of
parental L cells with virions were equivalent to those after
infection with ISVPs. However, viral titers after infection of
FIG. 1. Viral titers in parental L cells and independent mutant LX cell clones
after infection by virions and ISVPs. Monolayers of parental L cells and eight
independent mutant LX-cell clones (5 3 105 cells) were infected with either
virions or ISVPs of reovirus T1L at an MOI of 2 PFU per cell. After a 1-h
adsorption period, the inoculum was removed, fresh medium was added, and the
cells were incubated at 37°C for 24 h. Cells were frozen and thawed twice, and
viral titers in cell lysates were determined by plaque assay using L-cell monolay-
ers. The results are presented as mean viral titers for four independent experi-
ments. Error bars indicate standard deviations of the means.
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the mutant cell lines with ISVPs were approximately 1,000-fold
greater than those produced after infection with virions. For all
mutant LXDG subclones examined, yields of viral progeny
after infection with virions were ,10 PFU per input PFU (Fig.
1). Similar results were obtained with strain T3D (data not
shown), and the block to growth of both T1L and T3D was
apparent even after adsorption with viral inocula of 100 PFU
per cell (data not shown). These results indicate that cellular
mutations selected during persistent infection block steps in
the viral growth cycle prior to generation of ISVPs. The LXA1
and LXB2 cloned cell lines were used for subsequent studies.
Ultrastructure of parental, persistently infected, and mu-
tant L cells. The finding that mutant cells selected during
persistent infection do not support steps in viral replication
required to generate ISVPs suggested that mutant cells are
altered in endocytic function. To characterize changes in cel-
lular ultrastructure associated with blocks to reovirus entry, we
used electron microscopy to examine the morphology of unin-
fected L cells, persistently infected LDG cells, and cured
LXA1 cells (Fig. 2). Parental L cells had an unremarkable
appearance consisting of a large nucleus and uniform cyto-
plasm (Fig. 2A). No reovirus particles were found in thin
sections of either uninfected L cells or cured LXA1 cells. The
most striking aspect of viral infection observed in the persis-
tently infected cells was the presence of large, perinuclear
inclusions of virions (Fig. 2B, arrow). In a given plane of
section, viral inclusions were found in approximately 15% of
the persistently infected cells. All persistently infected LDG
cells examined contained large numbers of electron-dense,
membrane-bound vesicles (Fig. 2C and D). Cured cells also
contained numerous vesicular structures similar to those ob-
served in the persistently infected cells (Fig. 2E and F). Such
structures were not observed in uninfected L cells. Therefore,
mutant cells selected during persistent reovirus infection accu-
mulate electron-dense, membrane-bound vesicles.
Internalization and intracellular transport of reovirus viri-
ons in parental L cells and mutant LX cells. To determine
whether L cells and LX cells differ qualitatively in reovirus
uptake and intracellular transport, purified reovirus virions
were conjugated to the fluorescent dye Cy3 and adsorbed to
parental L cells and mutant LX cells at 4°C. Cells were washed
to remove unbound virus, warmed to 37°C, and examined by
confocal microscopy (Fig. 3). At 0 min postadsorption, reovirus
virions were observed at the periphery of both parental L cells
(Fig. 3A) and mutant LX cells (Fig. 3E). By 20 min postad-
sorption, virions were internalized and noted to be distributed
throughout the cytoplasm (Fig. 3B and F). By 40 and 60 min
postadsorption, virions were observed to coalesce in perinu-
clear regions of both cell types (Fig. 3C, D, G, and H), con-
sistent with the location of late endosomes and lysosomes (34).
Therefore, the internalization and subcellular localization of
reovirus virions are similar in both parental L cells and mutant
LX cells.
Intravesicular pHs of parental L cells and mutant LX cells.
To determine whether mutant LX cells contain a defect in
vesicular acidification, we measured the intravesicular pHs of
both parental L cells and mutant LX cells by using a double-
labeled fluorescein-tetramethylrhodamine dextran that is
taken into cells by receptor-mediated endocytosis. Upon entry
of the double-labeled dextran into acidified compartments, the
fluorescence of fluorescein is quenched while the fluorescence
of tetramethylrhodamine is unchanged (29, 57, 59). We first
generated a standard curve to correlate the F/TMR fluores-
cence ratio with pH by equilibrating permeabilized dextran-
labeled cells with buffers of known pH (Fig. 4A). We then
incubated both parental and mutant cells with the dual-labeled
dextran and examined cells by confocal microscopy. By extrap-
olation from the standard curve, the intravesicular pH of pa-
rental L cells was determined to be 5.2 while those of mutant
LXA1 and LXB2 cells were 5.1 and 5.0, respectively (Fig. 4B).
Thus, parental L cells and mutant LX cells have similar intra-
vesicular pHs, which suggests that the block to reovirus entry
exhibited by mutant LX cells is not due to a general defect in
acidification.
Localization of reovirus virions to acidic intravesicular com-
partments in parental L cells and mutant LX cells. To de-
termine whether reovirus virions are transported to acidified
organelles, we used the pH-sensitive LysoSensor Green DND-
189 probe, which is an acid-sensitive probe that accumulates
and fluoresces in acidified organelles of living cells (28). Both
parental L cells and mutant LX cells were stained with this
probe (data not shown), which confirms that both cell types
have an acidic intravesicular pH. In addition, treatment of both
parental L cells and mutant LX cells with ammonium chloride
quenched LysoSensor probe fluorescence (data not shown),
indicating that the fluorescence observed in parental and mu-
tant cells incubated with this probe is due to its accumulation
in acidified intracellular organelles.
To determine whether parental L cells and mutant LX cells
differ in the capacity to transport reovirus virions to acidified
organelles, both cell types were examined by confocal micros-
copy after incubation with the LysoSensor probe and Cy5-
conjugated reovirus virions (Fig. 5). Both the LysoSensor
probe and reovirus virions were observed to rapidly accumu-
late in perinuclear vesicular structures in both cell types (Fig.
5A, B, D, and E). When images of the fluorescent probe and
reovirus virions were merged, virions were observed to colo-
calize with the acid-sensitive probe in both parental and mu-
tant cells (Fig. 5C and F). These findings indicate that reovirus
virions localize to acidified compartments in both parental L
cells and mutant LX cells and suggest that the block to reovirus
growth in mutant cells is not due to a defect in transport of
virions to acidified intracellular compartments where viral dis-
assembly occurs (22, 55).
Disassembly of reovirus virions in parental L cells and mu-
tant LX cells. To determine whether mutant LX cells are
altered in the capacity to support proteolysis of the reovirus
outer capsid, radiolabeled virions of reovirus strain T1L were
adsorbed to parental L cells and mutant LX cells, and viral
structural proteins were analyzed by SDS-PAGE and autora-
diography at various times postadsorption (Fig. 6). In parental
L cells infected with T1L, degradation of the s3 protein and
generation of the 59-kDa d cleavage fragment of the m1C
protein were observed within 2 h postadsorption, consistent
with the formation of ISVPs (13, 17, 19, 44, 52, 55). However,
in both mutant LX cell lines, we did not detect generation of
the d cleavage fragment of m1C even after incubation for up to
8 h postadsorption. A gradual decrease in the intensity of all
protein bands was noted at late time points after viral adsorp-
tion to LX cells (Fig. 6). This was a consistent finding (data not
shown) and suggests that reovirus virions do not undergo or-
derly degradation after uptake into mutant cells. Therefore,
these results demonstrate that persistent reovirus infection se-
lects a mutation in cells that results in failure to support pro-
teolytic disassembly of virions to ISVPs.
Detection of lysosomal protease cathepsin L in parental L
cells and mutant LX cells. Reovirus disassembly is inhibited by
protease inhibitor E64 (6, 16), a noncompetitive inhibitor of
cysteine-containing proteases (7). This observation suggests
that the protease responsible for reovirus disassembly is a
lysosomal cysteine protease. The major cysteine proteases in
lysosomes are cathepsins B, H, and L, with cathepsin L being
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FIG. 2. Ultrastructural morphologies of uninfected, persistently infected, and cured L cells. (A) Uninfected parental L cells. (B, C, and D) Persistently infected LDG
cells. Note in panel B the large inclusion of virions (arrow). (D) Increased magnification of electron-dense vesicles from panel C. (E and F) Cured LXA1 cells. Note
the presence of electron-dense vesicles in cured cells. Bars, 5 mm.
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FIG. 3. Uptake of reovirus virions following adsorption to parental L cells and mutant LXA1 cells. Monolayers of L cells (A to D) and LXA1 cells (E to H) were
adsorbed with 10,000 particles per cell of Cy3-conjugated virions of reovirus strain T1L at 4°C for 45 min. Following removal of unbound virus, cells were incubated
at 37°C for 0 (A and E), 20 (B and F), 40 (C and G), or 60 (D and H) min and then fixed. Cells were visualized by confocal fluorescence microscopy.
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the most abundant cysteine protease in lysosomes of several
cell types (8, 11, 24, 27, 32). To assess whether parental and
mutant cells differ in cathepsin L expression, we used immu-
noblot assays to probe for cathepsin L in cytoplasmic extracts
and culture supernatants from both cell types (Fig. 7A). Ca-
thepsin L is synthesized as a 38-kDa inactive proenzyme pre-
cursor that is either secreted from cells or processed to a
30-kDa single-chain intermediate form, which is subsequently
cleaved in lysosomes to a two-chain mature form consisting of
a 23-kDa heavy chain and a 5-kDa light chain (25, 39, 49). The
proenzyme, single-chain, and heavy-chain forms of cathepsin L
can be detected by using an antiserum raised against murine
cathepsin L (18, 40, 41, 45). In parental L cells, the procathe-
psin L precursor, the single-chain intermediate, and the heavy-
chain mature form were detected in cytoplasmic extracts, and
the procathepsin L precursor was detected in the culture su-
pernatant (Fig. 7A). In sharp contrast, only the procathepsin L
precursor was detected in cytoplasmic extracts and culture
supernatants from the LXA1 and LXB2 cell lines. Bands cor-
responding to single chain and heavy chain were not detected
in either cytoplasmic extracts or culture supernatants from
either mutant cell line (Fig. 7A). These findings indicate that
mutant LX cells are altered in the generation of the mature,
proteolytically active form of cathepsin L.
Detection of lysosomal protease cathepsin B in parental L
cells and mutant LX cells. To determine whether the absence
of the mature form of cathepsin L is due to a general defect in
the processing of lysosomal enzymes, we determined the status
of cathepsin B in parental and mutant cells by using immuno-
blot assays. Cathepsin B is synthesized as a 37-kDa inactive
proenzyme precursor that is either secreted from cells or pro-
cessed to a 31- to 34-kDa single-chain intermediate form,
which is subsequently cleaved in lysosomes to a two-chain
mature form consisting of a 24- to 25-kDa heavy chain and a
5-kDa light chain (37, 46, 48). The presence of cathepsin B
heavy chain in cytoplasmic extracts and culture supernatants of
parental L cells and mutant LX cells was assessed by immu-
noblotting with an antiserum raised against human cathepsin B
(Fig. 7B). To ensure consistent conditions for the cathepsin L
and cathepsin B immunoblots, the cathepsin L blot was
stripped of cathepsin L immunoreactivity and reprobed with
the anti-cathepsin B antiserum. In both parental L cells and
mutant LX cells, the mature heavy-chain form of cathepsin B
was detected in cytoplasmic extracts (Fig. 7B). However, in
contrast to immunoblot analysis of cathepsin L expression, we
did not detect procathepsin B or the single-chain cathepsin B
intermediate in either cytoplasmic extracts or culture superna-
tants of either cell type. It is possible that differences in the
expression levels of the two enzymes or differences in the
half-lives of their respective precursors account for the inability
to detect cathepsin B intermediates. Nonetheless, these find-
ings indicate that the mutant cell lines are able to process
cathepsin B precursors to the mature form of the enzyme.
Thus, the defect in cathepsin L maturation in mutant cells
selected during persistent reovirus infection is not due to a
general defect in lysosomal enzyme processing.
Inhibition of cathepsin L processing by E64. To determine
whether the absence of mature cathepsin L in mutant LX cells
is due to alterations in its turnover, we treated parental L cells
and mutant LX cells with protease inhibitor E64 and used
immunoblot assays to probe for cathepsin L in cytoplasmic
extracts and culture supernatants from both cell lines (Fig. 8).
Treatment of cells with E64 leads to an accumulation of the
single-chain and heavy-chain forms of cathepsin L (49). In
parental L cells treated with E64, the single-chain and heavy-
chain forms accumulated in cytoplasmic extracts, and the pro-
cathepsin L precursor accumulated in the culture supernatant
(Fig. 8). In mutant LXA1 and LXB2 cells treated with E64, no
mature forms of cathepsin L were detected in cytoplasmic
extracts. Similar to findings with parental L cells, there was an
accumulation of the procathepsin L precursor in the culture
supernatants of both mutant cell lines after treatment with E64
(Fig. 8). Thus, the defect in expression of mature cathepsin L
in mutant LX cells does not appear to be caused by accelerated
degradation of the enzyme.
Sequence analysis of cDNA clones of procathepsin L-encod-
ing mRNA isolated from parental L cells and mutant LX cells.
Alterations within the proregion of cathepsin L are known to
inhibit processing steps required to generate the mature en-
zyme (18, 56). To determine whether the defect in cathepsin L
maturation in mutant LX cells is due to a mutation within
cathepsin L, we analyzed full-length sequences of cDNAs en-
coding preprocathepsin L obtained from parental L cells and
two mutant LX cell lines. The cDNAs encoding cathepsin L
derived from parental L cells and mutant LX cells were found
to be identical. Therefore, the defect in cathepsin L processing
cannot be ascribed to an intrinsic defect in cathepsin L but
rather to a defect in either its transport to the organelle in
which processing occurs or in the proteolytic machinery re-
quired to generate the mature enzyme.
Overexpression of murine procathepsin L in parental L
cells and mutant LX cells. To determine whether the defect in
cathepsin L maturation can be complemented by overexpres-
sion of procathepsin L, parental L cells and mutant LX cells
were transfected with a plasmid encoding murine procathepsin
L. Following transfection, cytoplasmic extracts and culture su-
pernatants were analyzed for mature forms of cathepsin L by
immunoblot assay (Fig. 9). Overexpression of procathepsin L
in parental L cells resulted in a modest accumulation of the
FIG. 4. Determination of intravesicular pHs of parental L cells and mutant
LX cells. (A) Standard curve correlating the F/TMR fluorescence ratio with pH.
Cells were incubated with double-labeled fluorescein-tetramethylrhodamine dex-
tran (0.1% [wt/vol]) at 37°C for 16 h. Cells were fixed, equilibrated for 1 h with
buffers of known pH (0.1 M sodium acetate [pH 4.0 and pH 5.0], 0.1 M sodium
phosphate [pH 6.0 and pH 7.0], and 0.1 M Tris [pH 8.0]), and visualized by
confocal fluorescence microscopy. Fluorescence intensities for fluorescein and
tetramethylrhodamine were determined for identical groups of 15 to 20 cells at
each pH standard. (B) Intravesicular pHs of parental L cells and mutant LX cells
determined by calculating the mean F/TMR fluorescence ratio for each cell type
and extrapolating from the standard curve, as indicated in panel A.
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heavy-chain form of cathepsin L in cytoplasmic extracts (Fig.
9A) and a substantial increase in procathepsin L in the culture
supernatant (Fig. 9B). Overexpression of procathepsin L in
mutant LXA1 and LXB2 cells, however, did not result in
detection of mature forms of cathepsin L in either cytoplasmic
extracts or culture supernatants. Similar to transfected paren-
tal L cells, a substantial increase in procathepsin L was de-
tected in the culture supernatants of transfected mutant LX
FIG. 5. Colocalization of reovirus virions to acidic compartments in parental L cells and mutant LX cells. Virions of reovirus strain T1L conjugated to Cy5 were
adsorbed to monolayers of parental L cells and mutant LXB2 cells (10,000 particles per cell) at 4°C for 45 min. Following removal of unbound virus, cells were incubated
in medium containing 3 mM LysoSensor Green probe at 37°C for 1.5 h. Cells were washed and visualized by confocal fluorescence microscopy. Acidic compartments
are indicated in red (A and D). Virions are indicated in green (B and E). In the merged image, yellow indicates colocalization of virions and acidic compartments (C
and F).
FIG. 6. Electrophoretic analysis of reovirus structural proteins after infection of parental L cells and mutant LX cells. Monolayers of parental L cells and mutant
LXA1 and LXB2 cells (107) were adsorbed with 10,000 particles per cell of purified 35S-labeled virions of reovirus strain T1L. After 1 h of adsorption at 4°C, the
inoculum was removed, fresh medium was added, and the cells were incubated at 37°C for the indicated intervals. Cells then were lysed and extracted with freon. Virus
particles contained in supernatants were pelleted by ultracentrifugation and solubilized in sample buffer. Equal volumes of samples were loaded into wells of a 10%
polyacrylamide gel. After electrophoresis, the gel was prepared for autoradiography and exposed to film. Viral proteins are labeled, and molecular mass standards (in
kilodaltons) are indicated.
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cells (Fig. 9B). In both parental and mutant cells, overexpres-
sion of procathepsin L resulted in detection of a protein band
migrating slightly slower than procathepsin L. This band likely
corresponds to a form of procathepsin L that has altered car-
bohydrate modification (18). Thus, the defect in processing or
transport of cathepsin L cannot be overcome by procathepsin
L overexpression.
Treatment of reovirus virions with purified cathepsin L. The
finding that mutant cells selected during persistent reovirus
infection do not express mature cathepsin L suggests that ca-
thepsin L is required for reovirus disassembly. To test directly
whether cathepsin L treatment results in conversion of reovi-
rus virions to ISVPs, purified virions of reovirus strain T1L
were incubated for various times with purified human cathep-
sin L (15). Treated virions were analyzed by SDS-PAGE for
changes in viral outer-capsid proteins indicative of ISVP for-
mation (Fig. 10A). Treatment with cathepsin L resulted in loss
of s3 protein and generation of the d fragment of m1C protein.
These changes in viral outer-capsid proteins are observed in
ISVPs generated by treatment of reovirus virions with intesti-
nal proteases in vitro (13, 17, 19, 44, 52, 55) (Fig. 10A) or after
infection of cells (6, 53–55) (Fig. 6). Thus, cathepsin L is
capable of mediating disassembly of reovirus virions to ISVPs.
We next performed experiments to determine whether
ISVPs generated by treatment of virions with cathepsin L dis-
play growth characteristics like those of ISVPs generated by
treatment with intestinal proteases. In contrast to virions, IS-
VPs generated by chymotrypsin treatment in vitro are capable
of bypassing blocks to viral disassembly exhibited by mutant
LX cells (22) (Fig. 1). Parental L cells and mutant LXA1 and
LXB2 cells were infected with either virions treated for various
times with cathepsin L or ISVPs generated by treatment of
virions with chymotrypsin, and viral yields were determined
after 24 h of virus growth (Fig. 10B). Viral yields in parental L
cells after infection with virions treated with cathepsin L for 0,
4, 8, and 16 h were equivalent to those after infection with
chymotrypsin-generated ISVPs. Viral yields in mutant LXA1
and LXB2 cells after infection with virions treated with cathep-
sin L for 16 h were equivalent to those after infection with
chymotrypsin-generated ISVPs. However, virions treated with
cathepsin L for 4 and 8 h produced viral yields in both mutant
LX cell lines that correlated with the extent of m1C-to-d cleav-
age but not with the loss of s3. Treatment of virions with
cathepsin L for 4 h resulted in complete degradation of s3 but
minimal m1C-to-d cleavage, as judged by Coomassie blue stain-
ing (Fig. 10A), yet these particles produced ,2 PFU per input
PFU after 24 h of growth in LX cells. Therefore, these results
indicate that treatment of reovirus virions with purified cathep-
sin L leads to generation of particles that have the biochemical
and growth properties of authentic ISVPs and suggest that
m1C-to-d cleavage is required for efficient growth of reovirus in
mutant LX cells.
DISCUSSION
Mutant cells selected during persistent reovirus infections of
murine L cells do not support growth of reovirus after infection
by virions but do so after infection by ISVPs generated in vitro
(reference 22 and this report). This observation suggests that
mutant cells do not support entry steps leading to formation of
ISVPs. Virions and ISVPs have identical requirements for
binding to reovirus receptors (44); however, ISVPs do not
require acid-dependent proteolysis to facilitate penetration
into the cytoplasm (6, 22, 55). In contrast to virions, ISVPs
FIG. 7. Immunoblot analysis of cathepsin L and cathepsin B expression in
cytoplasmic extracts and culture supernatants from parental L cells and mutant
LX cells. Monolayers of parental L cells and mutant LXA1 and LXB2 cells (107)
were incubated in serum-free medium for 6 h. Cellular proteins (C), normalized
for protein content, and secreted proteins (S), normalized for cell number, were
resolved in a 12% polyacrylamide gel, electroblotted onto a nitrocellulose mem-
brane, and immunoblotted with rabbit antisera raised against either murine
cathepsin L (A) or human cathepsin B (B). Horseradish peroxidase-conjugated
anti-rabbit immunoglobulin G antiserum was used as secondary antibody, and
proteins were visualized by chemiluminescence. Bands corresponding to pro-
cathepsin L (Pro-L), the single-chain form of cathepsin L (SC-L), the heavy-
chain form of cathepsin L (HC-L), and the heavy-chain form of cathepsin B
(HC-B) are indicated. Molecular mass standards (in kilodaltons) are shown.
FIG. 8. Effect of protease inhibitor E64 on steady-state levels and secretion
of cathepsin L from parental L cells and mutant LX cells. Monolayers of parental
L cells and mutant LXA1 and LXB2 cells (107) were incubated at 37°C for 18 h
in the presence or absence of 200 mM E64. Cellular proteins (C), normalized for
protein content, and secreted proteins (S), normalized for cell number, were
resolved in a 12% polyacrylamide gel, electroblotted onto a nitrocellulose mem-
brane, and immunoblotted with rabbit anti-cathepsin L antiserum. Horseradish
peroxidase-conjugated anti-rabbit immunoglobulin G antiserum was used as
secondary antibody, and proteins were visualized by chemiluminescence. Bands
corresponding to procathepsin L (Pro-L) and the single-chain (SC-L) and heavy-
chain (HC-L) forms of cathepsin L are indicated. Molecular mass standards (in
kilodaltons) are shown.
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likely penetrate membranes at the cell surface. ISVPs gener-
ated in vitro mediate release of 51Cr from preloaded L cells
(12, 30, 31, 36), and these particles induce conductance
through artificial planar lipid bilayers (58). Therefore, our
finding that mutant cells support growth of reovirus when
infection is initiated with ISVPs but not virions indicates that
cellular mutations selected during persistent reovirus infection
affect steps in reovirus entry required for the proteolytic dis-
assembly of the viral outer capsid.
We compared parental L cells and mutant LX cells for the
capacity to support internalization of reovirus virions, intracel-
lular virion transport, acidification of endosomal organelles,
and proteolytic activity required for outer capsid disassembly.
Parental and mutant cells did not differ in the capacity to
internalize virions or distribute them to a perinuclear compart-
ment. Intravesicular pHs were found to be equivalent in both
cell types, and virions were observed in both parental and
mutant cells to colocalize with an acid-sensitive probe. How-
ever, we found a striking alteration in the capacity of mutant
cells to support generation of ISVPs. After adsorption of reo-
virus virions to LX cells, we did not detect changes in viral
outer-capsid proteins indicative of ISVP formation, even after
prolonged periods of incubation. From these results, we con-
cluded that mutant cells are altered in the expression of a
protease that mediates cleavage of viral outer-capsid proteins
leading to formation of ISVPs.
We used immunoblot analysis to evaluate the expression of
lysosomal proteases in parental and mutant cells. We found
that both cell types synthesize and secrete the proenzyme form
of cathepsin L; however, only parental cells express the mature
two-chain form of this enzyme. This finding demonstrates that
mutant cells do not support maturation steps required for
formation of the active protease. Sequence analysis of pro-
cathepsin L-encoding cDNAs corresponding to mRNA iso-
lated from two mutant cell lines revealed no mutations. More-
over, the defect in cathepsin L maturation in mutant cells was
not complemented by transfection of a cDNA encoding pro-
cathepsin L. These findings indicate that the defect in cathep-
sin L maturation is extrinsic, most likely due to a mutation
affecting a protein involved in cathepsin L processing or trans-
port.
Cathepsin L is translated as a proenzyme precursor, glyco-
sylated on a single asparagine residue, and sorted for targeting
to lysosomes or secretory vesicles (reviewed in references 11,
33, and 34). In prelysosomes or lysosomes, procathepsin L is
processed to an enzymatically active single-chain intermediate
and finally to a two-chain mature form (25). The proteases that
mediate these processing steps have not been identified. How-
ever, it has been suggested that initial cleavage of the propep-
tide is not autocatalytic (49), which is consistent with our ob-
servation that E64 treatment does not induce cellular
accumulation of the proenzyme. Thus, in mutant cells, either
the enzyme that initially activates cathepsin L by cleavage of
the propeptide is altered or procathepsin L is not transported
to the compartment in which activation normally occurs.
The defect in cathepsin L maturation exhibited by mutant
cells selected during persistent reovirus infection likely results
from an alteration of a protein specifically required for cathep-
sin L activation or transport. This conclusion is supported by
analysis of steady-state levels of cathepsin B, which demon-
strates that mutant cells are not defective in generation of the
mature two-chain form of this related lysosomal protease. Al-
terations in phosphotransferase activity, mannose 6-phosphate
receptor expression, or mannose 6-phosphate receptor intra-
cellular transport would be expected to affect processing of all
lysosomal enzymes, as would a defect in acidification of the
prelysosomal compartment. Similarly, alterations in the activ-
ity of chaperonins responsible for the proper folding of cathep-
sin L would be anticipated to affect the folding and therefore
activities of many proteins. The fact that mutant cells lack the
lysosomal membrane whorls characteristic of lysosomal-stor-
age-disease lysosomes (43) suggests that most lysosomal en-
zymes reach lysosomes in the mutant cells. Therefore, the
defect in generation of mature cathepsin L in mutant cells is
probably not due to a global alteration in lysosomal enzyme
processing or transport. The relationship between the alter-
ation in cathepsin L maturation and the accumulation of elec-
tron-dense, membrane-bound vesicles in the cytoplasm of mu-
tant cells is not apparent from our studies. It is possible that
these organelles result from abnormalities in cathepsin L func-
tion or vesicular transport.
Our previous studies of persistent reovirus infections indi-
cate that viruses and cells coevolve by selection of mutations
that affect acid-dependent proteolysis of the viral outer capsid
during virus entry (6, 22, 61, 62). In this study, we found that
mutant cells selected during persistent infection do not gener-
ate the mature, proteolytically active form of cathepsin L. This
finding suggests that cathepsin L is required for conversion of
reovirus virions to ISVPs. We tested whether cathepsin L is
sufficient to mediate virion-to-ISVP conversion by treating viri-
FIG. 9. Effect of procathepsin L overexpression on steady-state levels and
secretion of cathepsin L from parental L cells and mutant LX cells. Monolayers
of parental L cells and mutant LXA1 and LXB2 cells at approximately 80%
confluence were transfected with a plasmid encoding murine procathepsin L and
incubated at 37°C for 72 h. Equal amounts of cellular proteins (A) and equal
amounts of secreted proteins (B) were resolved in 12% polyacrylamide gels,
electroblotted onto nitrocellulose membranes, immunoblotted with rabbit anti-
cathepsin L antiserum, and visualized by chemiluminescence. Bands correspond-
ing to procathepsin L (Pro-L) and the single-chain (SC-L) and heavy-chain
(HC-L) forms of cathepsin L are indicated. Molecular mass standards (in kilo-
daltons) are shown.
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ons with purified, recombinant cathepsin L. Both SDS-PAGE
analysis of viral proteins and assays of viral growth in mutant
LX cells indicate that cathepsin L treatment of virions leads to
generation of ISVPs. The first step in virion-to-ISVP conver-
sion appears to be the proteolysis of s3 protein (13, 17, 44, 52,
55). Sequences in s3 protein adjacent to amino acid 220 confer
sensitivity to a variety of proteases (42, 50), and this region of
s3 is postulated to be cleaved by lysosomal proteases during
viral disassembly (51). Cathepsin L requires hydrophobic res-
idues at the P2 and P3 positions for efficient proteolysis (8),
and sequences adjacent to position 220 in the deduced amino
acid sequence of s3 (valine220, methionine221, and valine222)
(26) conform to these requirements. Mutant cells might man-
ifest alterations in the expression of other lysosomal proteases
capable of converting virions to ISVPs. However, our results
are consistent with the hypothesis that cathepsin L is sufficient
to mediate reovirus disassembly in murine L cells.
Results reported here can be used to clarify mechanisms by
which mutant viruses and cells altered in virus entry are se-
lected during persistent reovirus infection. We propose that
during establishment of persistent infection, cytolytic reovi-
ruses select mutant cells defective in maturation of cathepsin
L. These cells, which do not support conversion of reovirus
virions to ISVPs, in turn select mutant viruses having altered
requirements for lysosomal proteases to facilitate viral disas-
sembly. In support of this model, mutant viruses selected dur-
ing persistent reovirus infection can grow in the presence of
protease inhibitor E64 (6). Thus, steps in reovirus disassembly
mediated by cathepsin L appear to be a focal point for virus-
cell coevolution during persistent reovirus infections of murine
L cells.
In this report, we describe the characterization of cells de-
fective in maturation of the lysosomal protease cathepsin L. To
our knowledge, this is the first description of a defect in a
cellular protease selected by persistent viral infection. This
observation suggests that modulation of proteolytic activity in
cellular endosomes plays a critical role in determining host
susceptibility to intracellular pathogens. Mutant cells defective
in cathepsin L maturation will be useful in our ongoing efforts
to dissect viral entry mechanisms and lysosomal enzyme pro-
cessing and transport pathways.
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